Bristol-Myers Squibb is the Founding Sponsor of BioLabs’ newest location, BioLabs@NYULangone. This BioLabs site was launched in partnership with NYU Langone Health. As part of the agreement, for each year of active sponsorship, Bristol-Myers Squibb can nominate up to three innovative life-sciences and biotech startup companies per year to take up residence in BioLabs’ facilities at 180 Varick Street in Manhattan. The nomination process will launch in early 2018.
“We are thrilled to have Bristol-Myers Squibb as Founding Sponsor in New York, and excited to have them as part of BioLabs’ growing roster of sponsors,” said BioLabs CEO Johannes Fruehauf, M.D., Ph.D. “Clearly, there is a huge pent-up need for our model in The City; our sponsors are helping make BioLabs@NYULangone the best place to start a science-based startup in New York.”
A Golden Ticket represents one underwritten bench space per year for one scientist at BioLabs, and a priority spot on the waiting list. The Golden Ticket also promotes collaboration among sponsors and the start-up companies; the program provides sponsors with early access to potentially transformational targets and technology, and the start-ups with the mentorship of their sponsor teams.
“At LabCentral in Cambridge, where Bristol-Myers Squibb Company is a Platinum Sponsor, BMS Golden Ticket winners to date were first-time CEOs, fresh out of academia working to move early-stage science from the lab bench toward clinical trials,” Fruehauf said. “They speak regularly of the valuable insights they have gained from interactions with Bristol-Myers Squibb.”